Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)

• Status: Completed
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy and safety of three concentrations of a development drug compared to ointment base (vehicle) in subjects with Atopic Dermatitis (AD).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer

Criteria

Inclusion Criteria:

• Signed written informed consent

• Diagnosis of atopic dermatitis according to Hanifin and Rajka Criteria

• Willingness of subject to follow all study procedures

• Willingness to avoid excessive exposure of diseased areas to natural or artificial sunlight

Exclusion Criteria:

• Pregnancy and breast-feeding

• Clinically relevant disease, which could interfere with the study conduct or the evaluation and interpretation of the study results

• Clinically manifested immunosuppressive disorder or known history of malignant disease

• History of relevant drug and/or food allergies